MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
Conformis Cash Conversion Cycle 2011-2025 | CFMS
Annual Cash Conversion Cycle Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 165 | 119 | 132 | 99.2 | 108 | 93.5 | 110 | 140 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 165 | 93.5 | 121 |
Quarterly Cash Conversion Cycle Conformis
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 182 | 243 | - | 170 | 152 | 145 | - | 156 | 101 | 150 | 46.5 | 131 | 123 | 117 | 50.9 | 107 | 98.7 | 101 | 54.7 | 102 | 119 | 105 | 58 | 101 | 97.2 | 96.6 | 61.8 | 117 | 112 | 110 | 71.1 | 153 | 125 | 127 | 58.5 | 120 | 63.4 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 243 | 46.5 | 112 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
156 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
246 | $ 3.82 | -1.04 % | $ 132 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
263 | $ 307.08 | -0.33 % | $ 8.66 B | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 45.69 | 1.24 % | $ 6.81 K | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
100 | $ 128.67 | 2.55 % | $ 224 B | USA |
 |
Boston Scientific Corporation
BSX
|
118 | $ 91.95 | -0.67 % | $ 135 B | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.18 | 10.56 % | $ 119 M |  France |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 9.58 | -2.84 % | $ 688 M | Israel |
 |
InMode Ltd.
INMD
|
180 | $ 14.35 | -1.1 % | $ 1.14 B | Israel |
 |
IRIDEX Corporation
IRIX
|
119 | $ 0.99 | 7.52 % | $ 16 M | USA |
 |
IRadimed Corporation
IRMD
|
267 | $ 96.99 | 0.79 % | $ 1.23 B | USA |
 |
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
137 | $ 163.04 | -1.44 % | $ 12.2 B | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 1.04 | -2.06 % | $ 107 M | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
240 | $ 12.5 | -1.66 % | $ 338 M | USA |
 |
FONAR Corporation
FONR
|
234 | $ 14.9 | 0.99 % | $ 97.7 M | USA |
 |
AxoGen
AXGN
|
195 | $ 30.0 | -1.3 % | $ 1.33 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
218 | $ 40.3 | -1.29 % | $ 1.24 B | USA |
 |
LivaNova PLC
LIVN
|
129 | $ 63.28 | 0.84 % | $ 3.43 B |  Britain |
 |
OrthoPediatrics Corp.
KIDS
|
723 | $ 17.83 | 1.31 % | $ 411 M | USA |
 |
Globus Medical
GMED
|
319 | $ 86.73 | 0.05 % | $ 11.8 B | USA |
|
LENSAR
LNSR
|
147 | $ 11.51 | -0.04 % | $ 133 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 13.51 | 0.67 % | $ 1.04 B | USA |
 |
Aziyo Biologics
AZYO
|
111 | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
251 | $ 19.79 | -0.85 % | $ 2.83 B | USA |
 |
Aethlon Medical
AEMD
|
-61.8 | $ 3.07 | -9.71 % | $ 4.79 M | USA |
 |
Establishment Labs Holdings
ESTA
|
355 | $ 72.39 | -0.17 % | $ 2.04 B |  Costa-rica |